IL110942A - GRB3-3 gene and its uses - Google Patents

GRB3-3 gene and its uses

Info

Publication number
IL110942A
IL110942A IL11094294A IL11094294A IL110942A IL 110942 A IL110942 A IL 110942A IL 11094294 A IL11094294 A IL 11094294A IL 11094294 A IL11094294 A IL 11094294A IL 110942 A IL110942 A IL 110942A
Authority
IL
Israel
Prior art keywords
grb3
vector
sequence
protein
grb2
Prior art date
Application number
IL11094294A
Other languages
English (en)
Hebrew (he)
Other versions
IL110942A0 (en
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL110942A0 publication Critical patent/IL110942A0/xx
Priority to IL12675698A priority Critical patent/IL126756A0/xx
Publication of IL110942A publication Critical patent/IL110942A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL11094294A 1993-09-15 1994-09-12 GRB3-3 gene and its uses IL110942A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL12675698A IL126756A0 (en) 1993-09-15 1998-10-26 Nucleotide sequences derived from the Grb3-3 gene capable of inhibiting the expression of GRB2 or GRB3-3 proteins and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9310971A FR2710074B1 (fr) 1993-09-15 1993-09-15 Gène GRB3-3, ses variants et leurs utilisations.

Publications (2)

Publication Number Publication Date
IL110942A0 IL110942A0 (en) 1994-11-28
IL110942A true IL110942A (en) 2001-12-23

Family

ID=9450882

Family Applications (2)

Application Number Title Priority Date Filing Date
IL11094294A IL110942A (en) 1993-09-15 1994-09-12 GRB3-3 gene and its uses
IL126756A IL126756A (en) 1993-09-15 1994-09-12 Antisense nucleotide sequences derived from the Grb3-3 gene that have the ability to inhibit the expression of Grb2 protein or Grb3-3 protein and their uses

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL126756A IL126756A (en) 1993-09-15 1994-09-12 Antisense nucleotide sequences derived from the Grb3-3 gene that have the ability to inhibit the expression of Grb2 protein or Grb3-3 protein and their uses

Country Status (27)

Country Link
US (2) US5831048A (fi)
EP (1) EP0719328B1 (fi)
JP (1) JP3794697B2 (fi)
KR (1) KR100330477B1 (fi)
CN (1) CN1098930C (fi)
AT (1) ATE196926T1 (fi)
AU (1) AU698819B2 (fi)
BR (1) BR9407693A (fi)
CA (1) CA2169938A1 (fi)
CZ (1) CZ288882B6 (fi)
DE (1) DE69426121T2 (fi)
DK (1) DK0719328T3 (fi)
ES (1) ES2152313T3 (fi)
FI (1) FI120499B (fi)
FR (1) FR2710074B1 (fi)
GR (1) GR3034600T3 (fi)
HU (1) HU221516B (fi)
IL (2) IL110942A (fi)
NO (1) NO319144B1 (fi)
NZ (1) NZ266162A (fi)
PL (1) PL178402B1 (fi)
PT (1) PT719328E (fi)
RU (1) RU2159815C2 (fi)
SK (1) SK281123B6 (fi)
UA (1) UA46715C2 (fi)
WO (1) WO1995007981A1 (fi)
ZA (1) ZA947059B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
US6423824B1 (en) 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
US5837844A (en) * 1995-06-07 1998-11-17 Biogen, Inc. CAIP-like gene family
US6171800B1 (en) 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
AU6342696A (en) * 1996-06-27 1998-01-14 Biogen, Inc. The caip-like gene family
US7309692B1 (en) 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
WO2001075164A2 (en) 2000-03-30 2001-10-11 Whitehead Institute For Biomedical Research Rna sequence-specific mediators of rna interference
DK2813582T3 (en) 2000-12-01 2017-07-31 Max-Planck-Gesellschaft Zur Förderung Der Wss E V Small RNA molecules that mediate RNA interference
EP1460898A4 (en) * 2002-01-03 2006-05-24 Univ Texas OLIGONUCLEOTIDES ANTISENSE WT1 INHIBITING BREAST CANCER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100860C (en) 1991-01-18 2003-11-25 Joseph Schlessinger A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
AU5136093A (en) * 1992-09-25 1994-04-26 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof

Also Published As

Publication number Publication date
FR2710074A1 (fr) 1995-03-24
DE69426121T2 (de) 2001-05-31
EP0719328B1 (fr) 2000-10-11
CN1133064A (zh) 1996-10-09
ES2152313T3 (es) 2001-02-01
AU698819B2 (en) 1998-11-05
USRE37952E1 (en) 2002-12-31
HU221516B (hu) 2002-11-28
RU2159815C2 (ru) 2000-11-27
PT719328E (pt) 2001-02-28
CN1098930C (zh) 2003-01-15
IL126756A (en) 2006-06-11
WO1995007981A1 (fr) 1995-03-23
JP3794697B2 (ja) 2006-07-05
NO960965D0 (no) 1996-03-08
NZ266162A (en) 1997-11-24
DK0719328T3 (da) 2000-11-13
ATE196926T1 (de) 2000-10-15
IL110942A0 (en) 1994-11-28
FR2710074B1 (fr) 1995-12-08
KR100330477B1 (ko) 2002-12-02
JPH09502357A (ja) 1997-03-11
EP0719328A1 (fr) 1996-07-03
CZ75896A3 (en) 1996-06-12
US5831048A (en) 1998-11-03
BR9407693A (pt) 1997-02-04
SK281123B6 (sk) 2000-12-11
NO960965L (no) 1996-03-08
FI120499B (fi) 2009-11-13
PL313445A1 (en) 1996-07-08
CA2169938A1 (fr) 1995-03-23
SK34596A3 (en) 1996-07-03
PL178402B1 (pl) 2000-04-28
HUT74273A (en) 1996-11-28
FI961202A (fi) 1996-03-14
NO319144B1 (no) 2005-06-27
DE69426121D1 (de) 2000-11-16
HU9600668D0 (en) 1996-05-28
ZA947059B (en) 1995-05-18
CZ288882B6 (cs) 2001-09-12
GR3034600T3 (en) 2001-01-31
AU6724794A (en) 1995-04-03
UA46715C2 (uk) 2002-06-17
FI961202A0 (fi) 1996-03-14

Similar Documents

Publication Publication Date Title
US6468985B1 (en) Retinoblastoma protein-interacting zinc finger proteins
USRE37952E1 (en) Grb3-3 cDNA and polypeptides
US6238918B1 (en) DNA sequence encoding the tumor suppressor gene ING1
US20020146774A1 (en) Smad2 phosphorylation and interaction with Smad4
US6323335B1 (en) Retinoblastoma protein-interacting zinc finger proteins
AU722973B2 (en) Grb3-3 gene, variants and uses thereof
US6124434A (en) Signal mediator protein that induces cellular morphological alterations
US6818744B1 (en) p53 regulatory protein called RB18A and uses thereof
US6747133B1 (en) Antibodies against the tumor suppressor gene ING1
KR100453478B1 (ko) 인간 원암 유전자 및 이에 의해 코드되는 단백질
AU741708B2 (en) A new cytokine family and uses thereof
JP2003024069A (ja) ＴｄＴ結合性新規タンパク質および当該タンパク質をコードする遺伝子

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees